7 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #SideEffects #Table ... #DecisionAid #Orals ... #DM2 #Diabetes ... #Pharmacology #Management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP ... #medications #table ... #comparison #management ... endocrinology #dm2
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... very tolerable medication ... Inhibitors #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... There is an ORAL ... very similar to DPP4s ... #Pharmacology #Dosing ... #Diabetes #DM2
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... empagliflozin and DPP4 ... #semaglutide #Diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... neuroexam - Oral ... Insulin dependent DM ... Diabetes regimen ... medical and surgical management
Coccidioidomycosis (Valley Fever) - Diagnosis and Management Summary

WHAT?
 • Coccidioidomycosis due to Coccidioides immitis or Coccidioides
Diagnosis and Management ... Older age • Diabetes ... arthroconidia may travel ... serologic analysis using ... treated with: oral